The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Phunware, Inc. (NASDAQ:PHUN – Free Report) – Equities researchers at HC Wainwright increased their FY2025 earnings estimates for shares of Phunware in a research note issued on Monday ...

Phunware (PHUN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Investors might want to bet on Phunware (PHUN), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one ...

Roth MKM lowered the firm’s price target on Phunware (PHUN) to $4.50 from $20 and keeps a Buy rating on the shares. The company’s FY24 bookings ...

Oramed Pharmaceuticals Inc (ORMP) is expected to report $-0.19 for 4Q. Phunware Inc (PHUN) is expected to report for 4Q. Relmada Therapeutics Inc (RLMD) is expected to report $-0.65 for 4Q.

H.C. Wainwright lowered the firm’s price target on Phunware (PHUN) to $3 from $6 and keeps a Neutral rating on the shares. The company’s ...

v. Phunware Inc., Del. Ch., No. 2022-0168, trial 3/26/25. At issue: Investors sued Phunware Inc. and the leaders of the mobile marketing and cryptocurrency services business in 2022, claiming the ...